AGL Insider Trading Activity and SEC Form 4 Filings
AGL insider trading summary
Over the past 12 months, insiders at agilon health, inc. (AGL) reported 2 open-market purchases worth $352K by 2 insiders and no sales on SEC Form 4. Net insider buying was $352K.
Latest AGL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 2, 2026 | Benjamin Shaker | Chief Markets Officer | Buy | $301K (500,000 @ $0.60) |
| Nov 12, 2025 | John William Wulf | Director | Buy | $51K (81,000 @ $0.63) |
| Mar 14, 2025 | Girish Venkatachaliah | Chief Technology Officer | Buy | $0 (9,429 @ $0.00) |
| Mar 14, 2025 | Benjamin Shaker | Chief Markets Officer | Buy | $0 (11,786 @ $0.00) |
| Mar 14, 2025 | Steven Sell | CEO & President | Buy | $0 (42,426 @ $0.00) |
| Dec 13, 2024 | Karen McLoughlin | Director | Buy | $55K (25,000 @ $2.20) |
| Dec 11, 2024 | Silvana Battaglia | Director | Buy | $50K (25,062 @ $2.01) |
| Dec 9, 2024 | Diana McKenzie | Director | Buy | $16K (7,500 @ $2.20) |
| Dec 5, 2024 | John William Wulf | Director | Buy | $98K (45,000 @ $2.18) |
| Nov 25, 2024 | Diana McKenzie | Director | Buy | $28K (12,500 @ $2.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.